Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Emerging properties of cannabinoid medicines in management of multiple sclerosis.

Literature DB >> 15866202

Emerging properties of cannabinoid medicines in management of multiple sclerosis.

Abstract

Use of cannabis as a medicine for numerous conditions has a well-documented history stretching back thousands of years. With the identification of an endogenous system of receptors and ligands in recent years, abundant experimental data have reinforced the anecdotal claims of people who perceive medicinal benefit from the currently illegal consumption of cannabis. This, combined with data from recent clinical trials, points to the prospect of cannabis as a medication in the treatment of multiple sclerosis and numerous other medical conditions.

Entities: Chemical

Mesh：

Substances：

Year: 2005 PMID： 15866202 DOI： 10.1016/j.tins.2005.03.006

Source DB: PubMed Journal: Trends Neurosci ISSN： 0166-2236 Impact factor: 13.837

Keyword Cloud
Cited

13 in total

1. Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis.

Authors: Jia Li; Weian Chen; Yu'an Li; Ying Chen; Zhangna Ding; Dehao Yang; Xu Zhang
Journal: Int J Clin Exp Pathol Date: 2015-09-01

2. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection.

Authors: Anke Witting; Lanfen Chen; Eiron Cudaback; Alex Straiker; Lisa Walter; Barry Rickman; Thomas Möller; Celia Brosnan; Nephi Stella
Journal: Proc Natl Acad Sci U S A Date: 2006-03-29 Impact factor: 11.205

Review 3. The endocannabinoid system as an emerging target of pharmacotherapy.

Authors: Pál Pacher; Sándor Bátkai; George Kunos
Journal: Pharmacol Rev Date: 2006-09 Impact factor: 25.468

4. [Impaction of a "sausage bread" in the esophagus--first manifestation of an eosinophilic esophagitis in a 17-year-old patient].

Authors: Erwin Gäbele; Esther Endlicher; Ina Zuber-Jerger; Wibke Uller; Fabian Eder; Jürgen Schölmerich
Journal: Med Klin (Munich) Date: 2009-05-16

9. Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.

Authors: Balapal S Basavarajappa
Journal: Curr Neuropharmacol Date: 2007 Impact factor: 7.363

Review 10. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.

Authors: Balapal S Basavarajappa; Ralph A Nixon; Ottavio Arancio
Journal: Mini Rev Med Chem Date: 2009-04 Impact factor: 3.862

Emerging properties of cannabinoid medicines in management of multiple sclerosis.

1. Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis.

2. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection.

Review 3. The endocannabinoid system as an emerging target of pharmacotherapy.

4. [Impaction of a "sausage bread" in the esophagus--first manifestation of an eosinophilic esophagitis in a 17-year-old patient].

Review 5. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.

Review 6. What we know and do not know about the cannabinoid receptor 2 (CB2).

7. Propagation through alginate encapsulation of axillary buds of Cannabis sativa L. - an important medicinal plant.

Review 8. Cannabinoid CB2 receptors in human brain inflammation.

9. Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.

Review 10. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.